Cargando…
P877: IXAZOMIB DARATUMUMAB AND LOW-DOSE DEXAMETHASONE IN INTERMEDIATE-FIT PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA; RESULTS OF THE INDUCTION AND MAINTENANCE TREATMENT OF THE PHASE II HOVON 143 STUDY
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430933/ http://dx.doi.org/10.1097/01.HS9.0000970412.25266.f8 |
| _version_ | 1785091078471286784 |
|---|---|
| author | Groen, Kaz Stege, Claudia Nasserinejad, Kazem de Heer, Koen van Kampen, Roel J.W. Leys, Rineke B.L. Thielen, Noortje Westerman, Matthijs Wu, Ka-Lung Ludwig, Inge Issa, Djamila E. Velders, Gerjo A. Vekemans, Marie-Christiane van de Donk, Niels W.C.J. Timmers, Gert-Jan de Boer, Fransien Tick, Lidwine W. van der Spek, Ellen de Waal, Esther G.M. Sohne, Maaike Sonneveld, Pieter Nijhof, Inger S. Klein, Saskia K. Levin, Mark-David Ypma, Paula F. Zweegman, Sonja |
| author_facet | Groen, Kaz Stege, Claudia Nasserinejad, Kazem de Heer, Koen van Kampen, Roel J.W. Leys, Rineke B.L. Thielen, Noortje Westerman, Matthijs Wu, Ka-Lung Ludwig, Inge Issa, Djamila E. Velders, Gerjo A. Vekemans, Marie-Christiane van de Donk, Niels W.C.J. Timmers, Gert-Jan de Boer, Fransien Tick, Lidwine W. van der Spek, Ellen de Waal, Esther G.M. Sohne, Maaike Sonneveld, Pieter Nijhof, Inger S. Klein, Saskia K. Levin, Mark-David Ypma, Paula F. Zweegman, Sonja |
| author_sort | Groen, Kaz |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10430933 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104309332023-08-17 P877: IXAZOMIB DARATUMUMAB AND LOW-DOSE DEXAMETHASONE IN INTERMEDIATE-FIT PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA; RESULTS OF THE INDUCTION AND MAINTENANCE TREATMENT OF THE PHASE II HOVON 143 STUDY Groen, Kaz Stege, Claudia Nasserinejad, Kazem de Heer, Koen van Kampen, Roel J.W. Leys, Rineke B.L. Thielen, Noortje Westerman, Matthijs Wu, Ka-Lung Ludwig, Inge Issa, Djamila E. Velders, Gerjo A. Vekemans, Marie-Christiane van de Donk, Niels W.C.J. Timmers, Gert-Jan de Boer, Fransien Tick, Lidwine W. van der Spek, Ellen de Waal, Esther G.M. Sohne, Maaike Sonneveld, Pieter Nijhof, Inger S. Klein, Saskia K. Levin, Mark-David Ypma, Paula F. Zweegman, Sonja Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430933/ http://dx.doi.org/10.1097/01.HS9.0000970412.25266.f8 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Groen, Kaz Stege, Claudia Nasserinejad, Kazem de Heer, Koen van Kampen, Roel J.W. Leys, Rineke B.L. Thielen, Noortje Westerman, Matthijs Wu, Ka-Lung Ludwig, Inge Issa, Djamila E. Velders, Gerjo A. Vekemans, Marie-Christiane van de Donk, Niels W.C.J. Timmers, Gert-Jan de Boer, Fransien Tick, Lidwine W. van der Spek, Ellen de Waal, Esther G.M. Sohne, Maaike Sonneveld, Pieter Nijhof, Inger S. Klein, Saskia K. Levin, Mark-David Ypma, Paula F. Zweegman, Sonja P877: IXAZOMIB DARATUMUMAB AND LOW-DOSE DEXAMETHASONE IN INTERMEDIATE-FIT PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA; RESULTS OF THE INDUCTION AND MAINTENANCE TREATMENT OF THE PHASE II HOVON 143 STUDY |
| title | P877: IXAZOMIB DARATUMUMAB AND LOW-DOSE DEXAMETHASONE IN INTERMEDIATE-FIT PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA; RESULTS OF THE INDUCTION AND MAINTENANCE TREATMENT OF THE PHASE II HOVON 143 STUDY |
| title_full | P877: IXAZOMIB DARATUMUMAB AND LOW-DOSE DEXAMETHASONE IN INTERMEDIATE-FIT PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA; RESULTS OF THE INDUCTION AND MAINTENANCE TREATMENT OF THE PHASE II HOVON 143 STUDY |
| title_fullStr | P877: IXAZOMIB DARATUMUMAB AND LOW-DOSE DEXAMETHASONE IN INTERMEDIATE-FIT PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA; RESULTS OF THE INDUCTION AND MAINTENANCE TREATMENT OF THE PHASE II HOVON 143 STUDY |
| title_full_unstemmed | P877: IXAZOMIB DARATUMUMAB AND LOW-DOSE DEXAMETHASONE IN INTERMEDIATE-FIT PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA; RESULTS OF THE INDUCTION AND MAINTENANCE TREATMENT OF THE PHASE II HOVON 143 STUDY |
| title_short | P877: IXAZOMIB DARATUMUMAB AND LOW-DOSE DEXAMETHASONE IN INTERMEDIATE-FIT PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA; RESULTS OF THE INDUCTION AND MAINTENANCE TREATMENT OF THE PHASE II HOVON 143 STUDY |
| title_sort | p877: ixazomib daratumumab and low-dose dexamethasone in intermediate-fit patients with newly diagnosed multiple myeloma; results of the induction and maintenance treatment of the phase ii hovon 143 study |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430933/ http://dx.doi.org/10.1097/01.HS9.0000970412.25266.f8 |
| work_keys_str_mv | AT groenkaz p877ixazomibdaratumumabandlowdosedexamethasoneinintermediatefitpatientswithnewlydiagnosedmultiplemyelomaresultsoftheinductionandmaintenancetreatmentofthephaseiihovon143study AT stegeclaudia p877ixazomibdaratumumabandlowdosedexamethasoneinintermediatefitpatientswithnewlydiagnosedmultiplemyelomaresultsoftheinductionandmaintenancetreatmentofthephaseiihovon143study AT nasserinejadkazem p877ixazomibdaratumumabandlowdosedexamethasoneinintermediatefitpatientswithnewlydiagnosedmultiplemyelomaresultsoftheinductionandmaintenancetreatmentofthephaseiihovon143study AT deheerkoen p877ixazomibdaratumumabandlowdosedexamethasoneinintermediatefitpatientswithnewlydiagnosedmultiplemyelomaresultsoftheinductionandmaintenancetreatmentofthephaseiihovon143study AT vankampenroeljw p877ixazomibdaratumumabandlowdosedexamethasoneinintermediatefitpatientswithnewlydiagnosedmultiplemyelomaresultsoftheinductionandmaintenancetreatmentofthephaseiihovon143study AT leysrinekebl p877ixazomibdaratumumabandlowdosedexamethasoneinintermediatefitpatientswithnewlydiagnosedmultiplemyelomaresultsoftheinductionandmaintenancetreatmentofthephaseiihovon143study AT thielennoortje p877ixazomibdaratumumabandlowdosedexamethasoneinintermediatefitpatientswithnewlydiagnosedmultiplemyelomaresultsoftheinductionandmaintenancetreatmentofthephaseiihovon143study AT westermanmatthijs p877ixazomibdaratumumabandlowdosedexamethasoneinintermediatefitpatientswithnewlydiagnosedmultiplemyelomaresultsoftheinductionandmaintenancetreatmentofthephaseiihovon143study AT wukalung p877ixazomibdaratumumabandlowdosedexamethasoneinintermediatefitpatientswithnewlydiagnosedmultiplemyelomaresultsoftheinductionandmaintenancetreatmentofthephaseiihovon143study AT ludwiginge p877ixazomibdaratumumabandlowdosedexamethasoneinintermediatefitpatientswithnewlydiagnosedmultiplemyelomaresultsoftheinductionandmaintenancetreatmentofthephaseiihovon143study AT issadjamilae p877ixazomibdaratumumabandlowdosedexamethasoneinintermediatefitpatientswithnewlydiagnosedmultiplemyelomaresultsoftheinductionandmaintenancetreatmentofthephaseiihovon143study AT veldersgerjoa p877ixazomibdaratumumabandlowdosedexamethasoneinintermediatefitpatientswithnewlydiagnosedmultiplemyelomaresultsoftheinductionandmaintenancetreatmentofthephaseiihovon143study AT vekemansmariechristiane p877ixazomibdaratumumabandlowdosedexamethasoneinintermediatefitpatientswithnewlydiagnosedmultiplemyelomaresultsoftheinductionandmaintenancetreatmentofthephaseiihovon143study AT vandedonknielswcj p877ixazomibdaratumumabandlowdosedexamethasoneinintermediatefitpatientswithnewlydiagnosedmultiplemyelomaresultsoftheinductionandmaintenancetreatmentofthephaseiihovon143study AT timmersgertjan p877ixazomibdaratumumabandlowdosedexamethasoneinintermediatefitpatientswithnewlydiagnosedmultiplemyelomaresultsoftheinductionandmaintenancetreatmentofthephaseiihovon143study AT deboerfransien p877ixazomibdaratumumabandlowdosedexamethasoneinintermediatefitpatientswithnewlydiagnosedmultiplemyelomaresultsoftheinductionandmaintenancetreatmentofthephaseiihovon143study AT ticklidwinew p877ixazomibdaratumumabandlowdosedexamethasoneinintermediatefitpatientswithnewlydiagnosedmultiplemyelomaresultsoftheinductionandmaintenancetreatmentofthephaseiihovon143study AT vanderspekellen p877ixazomibdaratumumabandlowdosedexamethasoneinintermediatefitpatientswithnewlydiagnosedmultiplemyelomaresultsoftheinductionandmaintenancetreatmentofthephaseiihovon143study AT dewaalesthergm p877ixazomibdaratumumabandlowdosedexamethasoneinintermediatefitpatientswithnewlydiagnosedmultiplemyelomaresultsoftheinductionandmaintenancetreatmentofthephaseiihovon143study AT sohnemaaike p877ixazomibdaratumumabandlowdosedexamethasoneinintermediatefitpatientswithnewlydiagnosedmultiplemyelomaresultsoftheinductionandmaintenancetreatmentofthephaseiihovon143study AT sonneveldpieter p877ixazomibdaratumumabandlowdosedexamethasoneinintermediatefitpatientswithnewlydiagnosedmultiplemyelomaresultsoftheinductionandmaintenancetreatmentofthephaseiihovon143study AT nijhofingers p877ixazomibdaratumumabandlowdosedexamethasoneinintermediatefitpatientswithnewlydiagnosedmultiplemyelomaresultsoftheinductionandmaintenancetreatmentofthephaseiihovon143study AT kleinsaskiak p877ixazomibdaratumumabandlowdosedexamethasoneinintermediatefitpatientswithnewlydiagnosedmultiplemyelomaresultsoftheinductionandmaintenancetreatmentofthephaseiihovon143study AT levinmarkdavid p877ixazomibdaratumumabandlowdosedexamethasoneinintermediatefitpatientswithnewlydiagnosedmultiplemyelomaresultsoftheinductionandmaintenancetreatmentofthephaseiihovon143study AT ypmapaulaf p877ixazomibdaratumumabandlowdosedexamethasoneinintermediatefitpatientswithnewlydiagnosedmultiplemyelomaresultsoftheinductionandmaintenancetreatmentofthephaseiihovon143study AT zweegmansonja p877ixazomibdaratumumabandlowdosedexamethasoneinintermediatefitpatientswithnewlydiagnosedmultiplemyelomaresultsoftheinductionandmaintenancetreatmentofthephaseiihovon143study |